Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BAS
Basis Energy Services, Inc.
BAS
|
+$159M |
| 2 |
Freeport-McMoran
FCX
|
+$137M |
| 3 |
Walt Disney
DIS
|
+$129M |
| 4 |
Alcoa
AA
|
+$98.7M |
| 5 |
CMA
Comerica
CMA
|
+$87.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$187M |
| 2 |
TWX
Time Warner Inc
TWX
|
+$177M |
| 3 |
ANDV
Andeavor
ANDV
|
+$166M |
| 4 |
Canadian Pacific Kansas City
CP
|
+$160M |
| 5 |
Union Pacific
UNP
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.65% |
| 2 | Consumer Discretionary | 12.25% |
| 3 | Healthcare | 12.08% |
| 4 | Energy | 7.79% |
| 5 | Materials | 6.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSGS
1201
DELISTED
CSG Systems International
CSGS
| $340K | ﹤0.01% |
+7,030
| New | +$303K |
|
|
SSRI
1202
DELISTED
Silver Standard Resources
SSRI
| $338K | ﹤0.01% |
+37,900
| New | +$383K |
|
|
WBMD
1203
DELISTED
WebMD Health Corp.
WBMD
| $335K | ﹤0.01% |
+6,766
| New | +$350K |
|
|
FRC
1204
DELISTED
First Republic Bank
FRC
| $334K | ﹤0.01% |
+3,624
| New | +$296K |
|
1205
AXIS Capital
AXS
$7.2B
| $332K | ﹤0.01% |
5,087
-249,292
| -98% | -$15M |
|
|
HIMX
1206
CALL
Himax Technologies
HIMX
$2.41B
| $331K | ﹤0.01% |
+54,800
| New | +$414K |
|
|
CHS
1207
DELISTED
Chicos FAS, Inc.
CHS
| $329K | ﹤0.01% |
22,890
-774,950
| -97% | -$10.7M |
|
1208
3D Systems Corp
DDD
$530M
| $327K | ﹤0.01% |
+24,600
| New | +$361K |
|
|
BCRH
1209
DELISTED
BLUE CAPITAL REINSURANCE HOLDINGS LTD.
BCRH
| $326K | ﹤0.01% |
17,669
-42,688
| -71% | -$772K |
|
1210
AbbVie
ABBV
$468B
| $319K | ﹤0.01% |
5,100
-1,731
| -25% | -$106K |
|
1211
Ashland
ASH
$3.33B
| $319K | ﹤0.01% |
5,964
+38
| +0.6% | +$2.09K |
|
1212
IQVIA
IQV
$42.8B
| $312K | ﹤0.01% |
+4,101
| New | +$314K |
|
1213
Atlantic Union Bankshares
AUB
$5.88B
| $310K | ﹤0.01% |
8,665
+565
| +7% | +$17.8K |
|
|
ISLE
1214
DELISTED
Isle of Capri Casinos Inc
ISLE
| $307K | ﹤0.01% |
+12,450
| New | +$281K |
|
1215
Live Nation Entertainment
LYV
$42.4B
| $306K | ﹤0.01% |
+11,505
| New | +$317K |
|
|
SRCI
1216
DELISTED
SRC Energy Inc
SRCI
| $304K | ﹤0.01% |
+34,079
| New | +$278K |
|
1217
Wabash National
WNC
$490M
| $301K | ﹤0.01% |
19,005
-31
| -0.2% | -$423 |
|
1218
Dine Brands
DIN
$454M
| $300K | ﹤0.01% |
3,900
+1,251
| +47% | +$102K |
|
1219
Benchmark Electronics
BHE
$2.61B
| $298K | ﹤0.01% |
9,760
+760
| +8% | +$20.8K |
|
|
ACRE
1220
Ares Commercial Real Estate
ACRE
$265M
| $297K | ﹤0.01% |
21,603
-4,119
| -16% | -$54.8K |
|
1221
Bloomin' Brands
BLMN
$996M
| $296K | ﹤0.01% |
16,443
-2,257
| -12% | -$40.9K |
|
1222
IBM
IBM
$222B
| $296K | ﹤0.01% |
1,865
-76,585
| -98% | -$11.7M |
|
|
PERY
1223
DELISTED
Perry Ellis International Inc
PERY
| $296K | ﹤0.01% |
11,900
| – | – |
|
1224
Papa John's
PZZA
$788M
| $295K | ﹤0.01% |
+3,445
| New | +$286K |
|
1225
Kirby Corp
KEX
$7.39B
| $294K | ﹤0.01% |
+4,416
| New | +$279K |
|
Similar funds
Dmitry Balyasny's Q4 2016 Portfolio in Review
As of Q4 2016, Dmitry Balyasny held 1,603 positions worth $18.6B, up 7.6% from $17.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Dmitry Balyasny's Q4 2016 filing shows 632 new, 338 increased, 353 reduced and 276 closed positions. Its largest new stake was Basis Energy Services, Inc.: 586,398 shares worth $20.7M. The largest sale was Eli Lilly, an estimated $187M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 9.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Dmitry Balyasny's largest Q4 2016 buy was Basis Energy Services, Inc.: 586,398 shares worth $20.7M.
- Dmitry Balyasny added most to Alcoa in Q4 2016, an estimated $98.7M increase.
- Dmitry Balyasny's biggest Q4 2016 reduction was Eli Lilly, cutting an estimated $187M.
- Dmitry Balyasny fully exited Canadian Pacific Kansas City in Q4 2016, selling an estimated $160M.
- Dmitry Balyasny's ten largest holdings make up 8.7% of its $18.6B portfolio in Q4 2016.
- Dmitry Balyasny opened 632 new positions and closed 276 in Q4 2016.
- Dmitry Balyasny's portfolio value rose 7.6% quarter-over-quarter to $18.6B.
Based on Balyasny Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.